Licata A G
Department of Medicine, University of Vermont College of Medicine, Burlington, USA.
Dermatol Nurs. 1998 Oct;10(5):334-6.
High-dose interferon has recently been approved as an adjuvant to surgery for treating newly diagnosed patients at high-risk for melanoma, particularly those with regional lymph node disease. The data supporting the indications for treatment and its side effects are reviewed.